CN104058967A - 适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 - Google Patents
适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 Download PDFInfo
- Publication number
- CN104058967A CN104058967A CN201410265537.0A CN201410265537A CN104058967A CN 104058967 A CN104058967 A CN 104058967A CN 201410265537 A CN201410265537 A CN 201410265537A CN 104058967 A CN104058967 A CN 104058967A
- Authority
- CN
- China
- Prior art keywords
- acid esters
- dicarboxylic acid
- indenes
- diethyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 ester compound Chemical class 0.000 title claims abstract description 42
- 150000001336 alkenes Chemical class 0.000 title claims abstract description 10
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 239000002685 polymerization catalyst Substances 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 62
- 239000001257 hydrogen Substances 0.000 claims description 62
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 30
- 229910052799 carbon Inorganic materials 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 22
- 150000002148 esters Chemical class 0.000 claims description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 15
- 238000006116 polymerization reaction Methods 0.000 claims description 15
- GTJTUNZBYODVSY-UHFFFAOYSA-N methyl cyclopenta-1,3-diene-1-carboxylate Chemical compound COC(=O)C1=CC=CC1 GTJTUNZBYODVSY-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims description 12
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Substances ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 8
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 8
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 125000004429 atom Chemical group 0.000 claims description 6
- 238000006555 catalytic reaction Methods 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- UWNADWZGEHDQAB-UHFFFAOYSA-N i-Pr2C2H4i-Pr2 Natural products CC(C)CCC(C)C UWNADWZGEHDQAB-UHFFFAOYSA-N 0.000 claims description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000005842 heteroatom Chemical group 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- 239000002243 precursor Substances 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 3
- AIDLAEPHWROGFI-UHFFFAOYSA-N 2-methylbenzene-1,3-dicarboxylic acid Chemical compound CC1=C(C(O)=O)C=CC=C1C(O)=O AIDLAEPHWROGFI-UHFFFAOYSA-N 0.000 claims description 2
- HUKMIFHEPZRLMM-UHFFFAOYSA-N 3-chloro-5-methyl-1h-pyrazole Chemical class CC1=CC(Cl)=NN1 HUKMIFHEPZRLMM-UHFFFAOYSA-N 0.000 claims description 2
- GTKNRXQSCVVESA-UHFFFAOYSA-N 3h-indazole Chemical compound C1=CC=C2CN=NC2=C1 GTKNRXQSCVVESA-UHFFFAOYSA-N 0.000 claims description 2
- 150000000531 4H-pyrans Chemical class 0.000 claims description 2
- MXWRAHVNYTVQFO-UHFFFAOYSA-N C(=CC=C)C(C(=O)O)C(=O)O Chemical class C(=CC=C)C(C(=O)O)C(=O)O MXWRAHVNYTVQFO-UHFFFAOYSA-N 0.000 claims description 2
- WUGDEVAETUBOLL-UHFFFAOYSA-N C(CCC)C1C(C(=O)O)(C=CC=C1C(=O)O)C Chemical group C(CCC)C1C(C(=O)O)(C=CC=C1C(=O)O)C WUGDEVAETUBOLL-UHFFFAOYSA-N 0.000 claims description 2
- XDWPAXYPCKNYNU-UHFFFAOYSA-N C(CCC)C1C(C(=O)O)=C(C(=CC1(C(=O)O)C)OC)OC Chemical group C(CCC)C1C(C(=O)O)=C(C(=CC1(C(=O)O)C)OC)OC XDWPAXYPCKNYNU-UHFFFAOYSA-N 0.000 claims description 2
- XMUXDESVQOZFGP-UHFFFAOYSA-N CCO[C](OCC)OCC Chemical compound CCO[C](OCC)OCC XMUXDESVQOZFGP-UHFFFAOYSA-N 0.000 claims description 2
- IGIVJYCZGNRZJE-UHFFFAOYSA-N COC(=O)C1(N=NC2=CC=CC=C12)C(=O)OC Chemical compound COC(=O)C1(N=NC2=CC=CC=C12)C(=O)OC IGIVJYCZGNRZJE-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- FRQMIZAJNRARKV-UHFFFAOYSA-N OC(=O)C1(C=CC=C2N=NC=C12)C(O)=O Chemical class OC(=O)C1(C=CC=C2N=NC=C12)C(O)=O FRQMIZAJNRARKV-UHFFFAOYSA-N 0.000 claims description 2
- 239000005864 Sulphur Substances 0.000 claims description 2
- 241000534944 Thia Species 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 230000032050 esterification Effects 0.000 claims description 2
- 238000005886 esterification reaction Methods 0.000 claims description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N methyl phenyl ether Natural products COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 239000003054 catalyst Substances 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 9
- 239000011954 Ziegler–Natta catalyst Substances 0.000 abstract description 6
- 229920000642 polymer Polymers 0.000 abstract description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 46
- 125000003118 aryl group Chemical group 0.000 description 34
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- 150000002220 fluorenes Chemical class 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 239000011949 solid catalyst Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical group [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- PQLFROTZSIMBKR-UHFFFAOYSA-N ethenyl carbonochloridate Chemical compound ClC(=O)OC=C PQLFROTZSIMBKR-UHFFFAOYSA-N 0.000 description 8
- 239000012074 organic phase Substances 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000010936 titanium Substances 0.000 description 8
- 229910052719 titanium Inorganic materials 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- SJJCABYOVIHNPZ-UHFFFAOYSA-N cyclohexyl-dimethoxy-methylsilane Chemical compound CO[Si](C)(OC)C1CCCCC1 SJJCABYOVIHNPZ-UHFFFAOYSA-N 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical compound CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- OAFMYIADTCIEFV-UHFFFAOYSA-N hexane;triethylalumane Chemical compound CCCCCC.CC[Al](CC)CC OAFMYIADTCIEFV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- XDKQUSKHRIUJEO-UHFFFAOYSA-N magnesium;ethanolate Chemical compound [Mg+2].CC[O-].CC[O-] XDKQUSKHRIUJEO-UHFFFAOYSA-N 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003335 steric effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明提供一种不饱和环取代二酸酯化合物、制备方法以及其在烯烃聚合催化剂组分制备中的应用。本发明的化合物用于给电子体制备齐格勒-纳塔催化剂组分时,能使催化剂组分具有优良的活性,并得到高等规度的聚合物产品。
Description
技术领域
本发明涉及一种不饱和环取代二酸酯化合物、该化合物的制备方法以及其在CH2=CHR烯烃聚合催化剂制备中的应用,其中R为氢或含1-12个碳原子的烃基基团。
背景技术
给电子体化合物能最大可能地改变烯烃聚合齐格勒-纳塔催化剂活性中心的性质,从而最大程度地改变催化剂的性能,因此高效齐格勒-纳塔催化剂的研究在某种意义上说,就是寻求更好的给电子体的研究。目前国内外对于内给电子体的研究主要集中于传统的脂肪酸酯和芳香酸酯化合物;二醚类(例如EP0361493,EP0728724)和琥珀酸酯类(例如WO9856834,WO0063261,WO03022894)化合物;以及二醇酯类(例如CN1580033,CN1580034,CN1580035)化合物等等。
但上述化合物作为烯烃聚合催化剂组分的给电子体在实际应用中都存在着一定的问题,如使用二醚类化合物制备的催化剂体系所得聚合物的分子量分布较窄,而琥珀酸酯类催化剂体系的聚合物产品分子量分布较宽,二醇酯类催化体系的活性往往不如二醚类体系理想。为了使催化剂能获得较为平衡的综合性能,开发出了各种新型的化合物并应用于制备齐格勒-纳塔催化剂。
但是采用上述化合物制备的齐格勒-纳塔催化剂组分在用于烯烃聚合时的活性/等规度的平衡并不令人满意,因此需要对其进行进一步研究和开发。
发明内容
本发明的目的在于提供一种特别适用于制备CH2=CHR烯烃聚合催化剂组分的不饱和环取代二酸酯化合物,其中R为氢或含1-12个碳原子的烃基基团。
本发明的另一目的在于提供该类化合物的制备方法。
本发明的再一目的在于提供该类化合物在CH2=CHR烯烃聚合催化剂制备中的应用。
为了实现本发明的目的,一种通式(Ⅰ)所示的不饱和环取代二酸酯化合物:
其中,A、B、C、D和E均选自碳原子或选自N、O和S中的杂原子;W、X、Y、Z和m为0或1;条件是
当n等于0时:
V)A、B、C和D均为碳原子,X、Y、Z和W为1;或
VI)A是氮原子,B、C和D均为碳原子,W为0,X、Y和Z为1;或
VII)A和D是氮原子,B和C为碳原子,W和Z为0,X和Y为1;或
VIII)D是氮原子,A、B和C均为碳原子,Z为0,W、X和Y为1;或
当n等于1时:
iv)A、B、C、D和E均为碳原子,m为2,W、X、Y和Z为1;或
v)E是氮原子,A、B、C和D均为碳原子,m为1,W、X、Y和Z为1;或
vi)E是氧原子,A、B、C和D均为碳原子,m为0,W、X、Y和Z为1;或
iii)E是硫原子,A、B、C和D均为碳原子,m为0,W、X、Y和Z为1;或
iv)D和E是氮原子,A、B和C均为碳原子,m为1,W、X和Y为1,Z为0。
R1和R2为相同或不相同的C1-C20的烃基,比如C1-C20直链或支链烷基、链烯基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基;相同或不同的R3-R7是氢原子、卤素原子、氧原子、硫原子和C1-C20的烃基,比如C1-C20直链或支链烷基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基;
上述R1-R7任意地包含一个或几个作为碳原子或氢原子或两者的取代物的R原子,R原子是杂原子,直链或支链的C1-C20烷基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基;其中R1-R7任意两个基团可以相互键合生成一个或多个螺环、稠环结构。
包括在通式(Ⅰ)中的化合物的具体实例是:
3,5-二苯基2H吡咯-2,2-二甲酸二乙酯;3-(3-氯苯基)-5-甲基-吡咯-2,2-二甲酸二乙酯;3-(3-溴苯基)-5-甲基-吡咯-2,2-二甲酸二乙酯;二乙基-3-(对氯苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;芴-9,9-二甲酸二甲酯;芴-9,9-二甲酸二乙酯;芴-9,9-二甲酸二正丙酯;芴-9,9-二甲酸二异丙酯;芴-9,9-二甲酸二正丁酯;芴-9,9-二甲酸二异丁酯;芴-9,9-二甲酸二正戊酯;芴-9,9-二甲酸二正己酯;芴-9,9-二甲酸二正庚酯;芴-9,9-二甲酸二正辛酯;9-甲酸甲酯-9-甲酸乙酯-芴;9-甲酸甲酯-9-甲酸正丙酯-芴;9-甲酸甲酯-9-甲酸异丙酯-芴;9-甲酸甲酯-9-甲酸正丁酯-芴;9-甲酸甲酯-9-甲酸异丁酯-芴,9-甲酸乙酯-9-甲酸正丙酯-芴;9-甲酸乙酯-9-甲酸异丙酯-芴;9-甲酸乙酯-9-甲酸正丁酯-芴;9-甲酸乙酯-9-甲酸异丁酯-芴;二甲基4H-苯并<g>硫杂<2,3-e>吲唑-4,4-二甲酸酯;二乙基-5-苯基-3(对甲苯)2H-吡咯-2,2-甲酸酯;二乙基-3(对甲氧基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二乙基5-(对硝基)-3-苯基-2H-吡咯-2,2-二甲酸酯;二乙基-2,3-二苯基-1H-茚-1,1-二甲酸酯;二乙基-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-2-(4-氯苯)-1H-茚-1,1-二甲酸酯;二乙基-2-(4-甲氧基苯基)-1H-茚-1,1-二甲酸酯;二甲基3-(4-甲基苯)-2-苯基-1H-茚-1,1-二甲酸酯;二甲基-3-(4-硝基苯)-1H-茚-1,1-二甲酸酯;二甲基氨基-4-五甲氧羰基-1,2,3,5,5-五甲氧羰基环戊二烯;3-苯基-茚-1,1-二甲酸甲酯;二甲基-5-(对氯苯)3-苯基-2H-吡咯-2,2-二甲酸酯;二甲基3,4-二(对氯苯)2H-吡咯-二甲酸酯;二甲基3-(对-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基3-(间-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基5-(间-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基5,6-二甲基-5H,6H-环戊二吲哚-11,11-二甲酸酯;1-(2-硝基苯硫)-2,3,4,5,5-甲酸甲酯-环戊二烯;1-(2,4-二硝基苯)-2,3,4,5,5-五甲酸甲酯-环戊二烯;甲基-2-叔丁基-3-甲基-1H-茚-1,1-二甲酸酯;二甲基3-甲基-2-三甲基硅-茚-1,1-二甲酸酯;二甲基3-甲基-2-苯基-茚-1,1-二甲酸酯;二乙基-2,3-二-正丙基-1H-茚-1,1-二甲酸酯;二甲基-3-羟甲基-2-苯基-1H-茚-1,1-二甲酸酯;二甲基-2-叔丁基-5,6-二甲氧基-3-甲基-1H-茚-1,1-二甲酸酯;二甲基-2-苯基-3-(硫杂-2-yl)-1H-茚-1,1-二甲酸酯;二甲基-3-(2-甲苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基3-(2-甲氧羰基苯基)-2苯基-1H-茚-1,1-二甲酸酯;二甲基3-(4-三氟甲基苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基3-(4-乙酰苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基-2-(环己1-烯)-3-(4-乙酰苯)-1H-茚-1,1-二甲酸酯;二甲基2-[(乙氧酰基)甲基]-1H-茚-1,1-二甲酸酯;1,1-二乙基-1H-茚-1,1-二甲酸酯;7-氯-5甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;5-氯-7-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;5-氨基-7-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;7-甲氧基-5-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;1-对甲苯氨基-2,3,4,5,5-五甲氧羰基环戊二烯;二甲基-3H-菲并〈9,10-c〉吡唑-3,3-二甲酸酯;3,3-二(甲氧羰基)-3H-吲唑;3,3-二(乙氧羰基)3H-吲唑;1-三氯甲基 -2,3,4,5,5-五甲氧羰基环戊二烯;1-(2-甲基-4-硝基苯)-五甲氧羰基环戊二烯;1-(2-碘-4-硝基苯)-五甲氧羰基环戊二烯;2-(2-碘-4-硝基苯)-1,3,4,5,5-五甲氧羰基环戊二烯;1-(2,4-二硝基苯)-2,3,4,5,5-五甲氧羰基环戊二烯;4-苄基-1,2,3,5,5-五聚(甲氧羰基)环戊二烯;3-苄基-1,2,4,5,5-五聚(甲氧羰基)环戊二烯;2-(三氟甲基)-5-羰基-3,3-二(甲氧羰基)-3H-吲哚;2-(三氟甲基)-5-羰基-7-甲基-3,3-二(甲氧羰基)-3H-吲哚;3-(三氟甲基)-5-羟基-7-甲氧基-3,3-二(甲氧羰基)-3H-吲哚;二乙基-3-苯基-5(对甲苯)2H-吡咯-2,2-二甲酸酯;二乙基-2-(4-氯苯)-5-吗啉-4H-咪唑-4,4-二甲酸酯;4,5,5-三甲酸甲酯-1,2,3-三氯环戊二烯;甲基-3-甲基-4-三甲基硅-环戊-2,4-二烯-1,1-二甲酸酯;二乙基-2,5-二苯基-4H-咪唑-4,4-二甲酸酯;二乙基-3-苄基-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(4-(甲氧羰基)苯基)2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(4-乙酰基苯)2-苯基-1H-茚-1,1-二甲酸酯;二乙基-2-甲氧甲基-1H-茚-1,1-二甲酸酯;二甲基-2-叔丁基-1H-茚-1,1-二甲酸酯;二乙基-2-叔丁基-1H-茚-1,1-二甲酸酯;二甲基2-正丁基-1H-茚-1,1-二甲酸酯;二乙基2-正丁基-1H-茚-1,1-二甲酸酯;二乙基2-正己基-1H-茚-1,1-二甲酸酯;二乙基-2-(3-氰基-1-丙基)-1H-茚-1,1-二甲酸酯;二乙基-2-二乙氧甲基-1H-茚-1,1-二甲酸酯;二乙基-2-(4-甲氧苯基)-1H-茚-1,1-二甲酸酯;二乙基-2-(1-环己烯)-1H-茚-1,1-二甲酸酯;二乙基-2-(环己基)-1H-茚-1,1-二甲酸酯;二乙基-3-(3-甲苯)-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(3-硝基苯)-2-苯基-1H-茚-1,1-二甲酸酯;二乙基13H-茚并[1,2-e]-菲-13,13-二甲酸酯;二乙基-2-己基-3-(4-甲氧苯基)1H-茚-1,1-二甲酸酯;环戊[c]硫杂-5,5-二甲酸乙酯;4-[4-[4-(甲基磺酸)苯]1,1-二(甲氧基)环戊-2,4-二烯-3-基]吡啶;芴-4,9,9-二甲酸-4-叔丁基-9,9-二甲酯;4-(4-氨基-吡啶-3-基氨甲酰基)-芴-9,9-二甲酸甲酯;4-(3-氨基-吡啶-4-基氨甲酰基)-芴-9,9-二甲酸二甲酯;二乙基-3-碘-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-正戊基-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-(3甲氧苯基)-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-(萘-2-基)-1H-茚-1,1-二甲酸酯;二正己基-芴-9,9-二甲酸酯;二正庚基-芴-9,9-二甲酸酯;二乙基-2-苯-3H-茚-3,3-二甲酸酯;二乙基-2-溴-1H-茚-1,1-二甲酸酯;
1-乙基-1-甲基-环己-2,5-二烯-1,1-二甲酸酯;N,4,4-三乙氧碳基-1,4-二氢-吡啶;2,6-二苯基-4,4-二甲氧羰基-4H-吡喃;2,6-二苯基-4,4-二甲氧羰基-1,4-二氢吡啶;2,6-二(4-氯苯)-4,4-二甲氧羰基-4H-吡喃;2,6-二(4-甲氧苯基)-4,4-二甲氧羰基-4H-吡喃;2,6-二(4-氯苯)-4,4-二甲氧羰基-1,4-二氢吡啶;2,6-二(4-甲氧苯基)-4,4-二甲氧羰基-1,4-二氢吡啶;1-环戊基-4,4-二(甲氧羰基)-1,4-二氢吡啶;1-正己基-4,4-二(甲氧羰基)-1,4-二氢吡啶;1-甲氧-6,6-二甲酰氧甲基-环己-1,4-二烯;二甲基1,4-二氢萘-1,1-二甲酸酯;2,6-二(4- 氯苯)-4,4-二甲氧酰基-4H-噻喃;二乙基-3-溴-1,4-二氢-1-甲基pyridazino[3,4-b]喹喔啉-4,4-二甲酸酯;二乙基-5-溴-3-苯基-1,4-二氢哒嗪-4,4-二甲酸酯;三己基-3-苯基-1,4-二氢哒嗪-4,4,5-三甲酸酯;1-苯乙基-二(甲氧酰基)1,4-二氢吡啶;二乙基-2-甲基-6-苯(4H-吡喃)4,4-二甲酸酯;1-(2-萘甲基)-4,4-二(甲氧酰基)-1,4-二氢吡啶;二甲基-3-乙酰基-1-甲基喹啉-4,4(1H)-二甲酸酯。
通式(Ⅰ)的化合物优选包括通式(Ⅱ)的化合物:
其中,R1-R6基团如通式(Ⅰ)中的定义。
通式(Ⅱ)的化合物优选包括通式(Ⅲ)的化合物:
其中R1、R2基团如通式(Ⅰ)中的定义,R’为相同或不相同的氢、卤原子、直链或支链的C1-C20烷基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基。
通式(Ⅱ)或(Ⅲ)所示的五元环化合物中,较适宜的具体化合物实例有:
芴-9,9-二甲酸二甲酯;芴-9,9-二甲酸二乙酯;芴-9,9-二甲酸二正丙酯;芴-9,9-二甲酸二异丙酯;芴-9,9-二甲酸二正丁酯;芴-9,9-二甲酸二异丁酯;芴-9,9-二甲酸二正戊酯;芴-9,9-二甲酸二正己酯;芴-9,9-二甲酸二正庚酯;芴-9,9-二甲酸二正辛酯;9-甲酸甲酯-9-甲酸乙酯-芴;9-甲酸甲酯-9-甲酸正丙酯-芴;9-甲酸甲酯-9-甲酸异丙酯-芴;9-甲酸甲酯-9-甲酸正丁酯-芴;9-甲酸甲酯-9-甲酸异丁酯- 芴,9-甲酸乙酯-9-甲酸正丙酯-芴;9-甲酸乙酯-9-甲酸异丙酯-芴;9-甲酸乙酯-9-甲酸正丁酯-芴;9-甲酸乙酯-9-甲酸异丁酯-芴。
本发明的另一目的是提供一种不饱和环取代二酸酯化合物的合成方法,通式(Ⅰ)所示的化合物可以通过各种反应合成。其中之一是通过下式三步反应合成(可参见US4564700A1;Journal of the Chemical Society,1949,P2182,2185;Analytical Chemistry,vol.32,NO.4,April1960):
A)将相应的含两个氢的环状化合物与二氧化碳和烷基锂试剂反应(见下式A1),或与烷基二甲酯和氢化钠反应制备得环烃基取代甲酸(见下式A2),各取代基同通式(Ⅰ)中的定义;
B)将上步产物与相应的醇R1OH反应酯化为甲酸酯,或者与合适的酯类前体直接加成为环烃取代甲酸脂;
C)将上步产物与与合适的含酰氧基的卤化物前体加成来制备。
例如,芴-9-甲酸甲酯-9-甲酸乙酯可以用芴与正丁基锂反应制备芴甲酸,再采用步骤B和C制备得到。具体反应式如下:
此外,当不饱和环取代二酸酯化合物R1和R2相同时,可用相应的不饱和环取代化合物直接与锂试剂(如正丁基锂或者二异丙基胺基锂)和卤代甲酸酯一步反应制备得到,各取代基同通式(Ⅰ)中的定义(可参见Tetrahedron Letters50(2009)6057-6059):
例如,芴-9,9-二甲酸二乙酯的制备反应式如下:
本发明所述的环取代二酸酯化合物在制备CH2=CHR烯烃聚合催化剂中的应用。其中R为氢或含1-12个碳原子的烃基基团。
本发明采用具有特定结构的双官能团化合物,即如通式(Ⅰ)所示的不饱和环 取代的二酸酯化合物,由于酯键的氧具有较强的配位效果,且在催化剂的制备过程中相对稳定,因此对催化剂的活性和等规度起到积极有效的作用。该类化合物所含有的特定的环取代结构,具有位阻效应并且能固定二酯双官能团的立体构型,在参与催化剂活性中心的形成以及对提高催化剂的立体定向性具有积极的作用。经试验验证,在将该类化合物用于给电子体制备齐格勒-纳塔催化剂组分时,能使催化剂组分具有优良的活性,通过聚合能得到高等规度的聚合物产品。
具体实施方式
下面用实施例进一步描述本发明,有利于对本发明及其优点、效果更好的了解,但所述实施例仅用于说明本发明而不是限制本发明。
不饱和环取代二酸酯化合物的制备
实施例1 芴-9-甲酸甲酯-9-甲酸乙酯的合成
步骤A:于氮气保护下向1000mL三口烧瓶中依次加入18g氢化钠、50g芴、150mL甲苯,开启机械搅拌,升温至125℃回流,保持反应4h;降温至90℃,往烧瓶内缓慢滴加146.1g碳酸二乙酯,于1.5h内滴完,滴完后继续反应3h;冷却到20℃,缓慢滴入60g浓盐酸和75g水的混合物,并控制温度不超过40℃;过滤,分离出有机相,用水洗至中性,有机相旋蒸,得到红棕色液体;将旋蒸所得液体和157.4g乙酸及63g10%的盐酸一起回流过夜;将混合物降至20℃,分液;有机相旋蒸后加入30%NaOH溶液,调节pH值至8~9,用乙酸乙酯萃取,保留水相。水相加入浓盐酸调节pH值至5-6后用乙酸乙酯萃取,保留有机相,有机相旋蒸;产物用乙酸乙酯溶解,冰冻重结晶;过滤,粗产品用己烷洗涤。得到无色晶体约10g,熔点:228-230℃。
步骤B:250mL三口瓶中,加入9-甲酸芴2g(9.5mmol),甲醇(30mL),浓硫酸(0.2mL);加热回流2h;冷却至室温;反应液倒入饱和碳酸氢钠溶液中,乙酸乙酯萃取二次(30mL*2),合并有机相,饱和食盐水洗(30mL*1),减压蒸馏,得到黄色固体,油泵抽干,得1.8g粗产品,熔点62-65℃。
步骤C:250mL三口圆底烧瓶中加入甲醇(20mL),金属钠(0.12g,5mmol),冰浴下待金属钠完全溶解无气泡冒出后,加入9-甲酸甲酯芴(0.56g,2.5mmol),完全溶解,呈黄色,搅拌5min后加入氯甲酸乙酯(0.8g,7.5mmol);搅拌30min,倒入水溶液中,用二氯甲烷萃取(20mL*2)后改用乙酸乙酯萃取两次(50mL*2)合并有机相,饱和食盐水洗(50mL*1),旋蒸走液体,己烷洗涤,粗产物用石油醚重结晶,得到产品,106-109℃。
芴-9-甲酸甲酯-9-甲酸乙酯的1H-NMR(CDCl3)δ(ppm):0.982-1.014(t,3H,甲基氢),3.758(s,3H,氧邻甲基氢),4.130-4.156(m,2H,氧邻亚甲基氢),7.356-7.388(t,2H,芳环氢),7.439-7.470(t,2H,芳环氢),7.714-7.728(d,2H,芳环氢), 7.790-7.7804(d,2H,芳环氢)。
实施例2 芴-9,9-二甲酸二乙酯的合成
将(1.6M,15mmol)的正丁基锂/己烷溶液在-78℃下滴加到含有16mmol二异丙基胺的20mL四氢呋喃溶液中,上述溶液在-78℃下搅拌45分钟,并在0℃下搅拌20分钟之后再降温到-78℃。-78℃下将含有7.0mmol芴的20mL四氢呋喃溶液在30分钟内滴加到上述搅拌着的溶液中,将33mmol的氯甲酸乙酯加入上述混合物中。反应体系升温至室温,并在室温下搅拌3小时。将上述反应混合物倒入100mL水中,用***萃取(三次萃取,每次50mL***),有机相用硫酸镁干燥,浓缩后所得粗产品用石油醚重结晶,得到产品,100-101℃。
芴-9,9-二甲酸二乙酯的1H-NMR(CDCl3)δ(ppm):0.932-0.962(t,6H,甲基氢),4.132-4.158(m,4H,氧邻亚甲基氢),7.392-7.424(t,2H,芳环氢),7.448-7.480(t,2H,芳环氢),7.734-7.748(d,2H,芳环氢),7.890-7.906(d,2H,芳环氢)
实施例3 芴-9,9-二甲酸二甲酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸甲酯。
芴-9,9-二甲酸二甲酯的1H-NMR(CDCl3)δ(ppm):3.759(s,6H,甲基氢),7.359-7.392(t,2H,芳环氢),7.443-7.475(t,2H,芳环氢),7.720-7.735(d,2H,芳环氢),7.799-7.7814(d,2H,芳环氢)。
实施例4 芴-9,9-二甲酸二正丙酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸正丙酯。
芴-9,9-二甲酸二正丙酯的1H-NMR(CDCl3)δ(ppm):0.936-0.966(t,6H,甲基氢),1.664-1.735(m,4H,亚甲基氢),4.171-4.197(t,4H,氧邻亚甲基氢),7.389-7.421(t,2H,芳环氢),7.449-7.481(t,2H,芳环氢),7.737-7.752(d,2H,芳环氢),7.887-7.902(d,2H,芳环氢)。
实施例5 芴-9,9-二甲酸二异丙酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸异丙酯。
芴-9,9-二甲酸二异丙酯的1H-NMR(CDCl3)δ(ppm):1.282-1.295(t,12H,甲基氢),5.012-5.062(m,4H,氧邻次甲基氢),7.215-7.295(t,2H,芳环氢),7.307-7.354(t,2H,芳环氢),7.356-7.371(d,2H,芳环氢),7.654-7.686(d,2H,芳环氢)。
实施例6 芴-9,9-二甲酸二正丁酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸正丁酯。
芴-9,9-二甲酸二正丁酯的1H-NMR(CDCl3)δ(ppm):0.937-0.967(t,6H,甲基氢),1.363-1.438(m,4H,亚甲基氢),1.642-1.699(m,4H,亚甲基氢),4.220-4.246(t,4H,氧临亚甲基氢),7.394-7.426(t,2H,芳环氢),7.447-7.479(t,2H,芳环氢),7.734-7.749(d,2H,芳环氢),7.889-7.904(d,2H,芳环氢)。
实施例7 芴-9,9-二甲酸二异丁酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸异丁酯。
芴-9,9-二甲酸二异丁酯的1H-NMR(CDCl3)δ(ppm):0.919-0.932(d,12H,甲基氢),1.936-2.016(m,2H,次甲基氢),3.982-3.995(d,4H,氧邻亚甲基氢),7.372-7.405(t,2H,芳环氢),7.440-7.473(t,2H,芳环氢),7.728-7.743(d,2H,芳环氢),7.868-7.883(d,2H,芳环氢)。
实施例8 芴-9,9-二甲酸二苄基酯的合成
合成步骤同实施例2,不同之处为将氯甲酸乙酯换为氯甲酸苄基酯。
芴-9,9-二甲酸二苄基酯的1H-NMR(CDCl3)δ(ppm):5.186-5.212(s,4H,亚甲基氢),7.372-7.405(t,2H,芳环氢),7.384-7.426(t,6H,芳环氢),7.440-7.473(t,2H,芳环氢),7.478-7.602(d,4H,芳环氢),7.728-7.743(d,2H,芳环氢),7.868-7.883(d,2H,芳环氢)。
表1环取代芴二酸酯实例
固体催化剂组分的制备
实施例中制备催化剂的操作均在高纯氮气保护下进行。具体实施例如下。
实施例9
在500ml经氮气充分置换的带有搅拌的5口烧瓶中,加入10g二乙氧基镁和80mL甲苯制备悬浮液,然后维持在-15℃滴加四氯化钛20mL,滴加完毕后将***缓慢升温至10℃后滴加四氯化钛60mL,之后再缓慢升温至80℃,加入3.5g芴-9-甲酸甲酯-9-甲酸乙酯,然后继续升温至120℃恒温2小时,然后将液体压滤干净,滤去液体,所得的固体用120mL四氯化钛在125℃洗涤3次。所得的固体用150mL己烷在60℃洗涤2次,室温洗涤2次,滤去液体并干燥,得到10.43g固体粉末即为固体催化剂组分,分析钛含量为3.96(wt)%,芴二酸酯含量为10.29(wt)%。
实施例10
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二甲酯,得到固体催化剂组分,分析钛含量为2.9(wt)%,芴二酸酯含量为13.74(wt)%。
实施例11
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二乙酯,得到固体催化剂组分,分析钛含量为3.04(wt)%,芴二酸酯含量为16.50(wt)%。
实施例12
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二正丙酯,得到固体催化剂组分,分析钛含量为2.59(wt)%,芴二酸酯含量为11.19(wt)%。
实施例13
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二异丙酯,得到固体催化剂组分,分析钛含量为4.07(wt)%,芴二酸酯含量为5.35(wt)%。
实施例14
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二正丁酯,得到固体催化剂组分,分析钛含量为3.10(wt)%,芴二酸酯含量为8.47(wt)%。
实施例15
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二异丁酯,得到固体催化剂组分,分析钛含量为3.47(wt)%,芴二酸酯含量为11.69(wt)%。
实施例16
催化剂组分制备步骤同实施例,不同之处为将芴-9-甲酸甲酯-9-甲酸乙酯换为芴-9,9-二甲酸二苄基酯,得到固体催化剂组分,分析钛含量为3.11(wt)%,芴二酸酯含量为7.79(wt)%。
聚合
以固体催化剂作为烯烃聚合催化剂的组分来进行聚合评价:
在5L不锈钢反应釜经氮气充分置换后,加入5mL浓度为0.5mol/L的三乙基铝己烷溶液和1mL浓度为0.1mol/L的甲基环己基二甲氧基硅烷(CMMS)己烷溶液及制备的催化剂10mg,然后加入10mL己烷冲洗加料管线,再加入2L(标准状态下)氢气,和2.5L精制丙烯,控制反应在20℃预聚5分钟,升温至70℃,在此温度下聚合反应1小时。反应结束后,将反应釜降温并停搅拌排出反应产物,经干燥得到聚合物。(聚合物的堆积密度采用JB/T2412-2008方法,等规度采用JB/T3682-2000方法。)
表2催化剂性能
表2聚合结果显示,用选自不饱和环取代二酸酯化合物的芴二酸酯作为内给电子体制备的催化剂,用于丙烯聚合时,能取得较高水平的活性,并且在标准聚合条件下配合甲基环己基二甲氧基硅烷外给电子体所制备的聚丙烯具有高于97%的等规度。
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。
Claims (7)
1.一种通式(Ⅰ)所示的不饱和环取代二酸酯化合物:
其中,A、B、C、D和E均选自碳原子或选自N、O和S中的杂原子;W、X、Y、Z和m为0或1;条件是
当n等于0时:
I)A、B、C和D均为碳原子,X、Y、Z和W为1;或
II)A是氮原子,B、C和D均为碳原子,W为0,X、Y和Z为1;或
III)A和D是氮原子,B和C为碳原子,W和Z为0,X和Y为1;或
IV)D是氮原子,A、B和C均为碳原子,Z为0,W、X和Y为1;或
当n等于1时:
i)A、B、C、D和E均为碳原子,m为2,W、X、Y和Z为1;或
ii)E是氮原子,A、B、C和D均为碳原子,m为1,W、X、Y和Z为1;或
iii)E是氧原子,A、B、C和D均为碳原子,m为0,W、X、Y和Z为1;或
i)E是硫原子,A、B、C和D均为碳原子,m为0,W、X、Y和Z为1;或
ii)D和E是氮原子,A、B和C均为碳原子,m为1,W、X和Y为1,Z为0。
R1和R2为相同或不相同的C1-C20的烃基,比如C1-C20直链或支链烷基、链烯基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基;相同或不同的R3-R7是氢原子、卤素原子、氧原子、硫原子和C1-C20的烃基,比如C1-C20直链或支链烷基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基;
上述R1-R7任意地包含一个或几个作为碳原子或氢原子或两者的取代物的R原子,R原子是杂原子,直链或支链的C1-C20烷基,C3-C20环烷基,C6-C20芳基,C7-C20 烷芳基和C7-C20芳烷基;其中R1-R7任意两个基团可以相互键合生成一个或多个螺环、稠环结构。
2.根据权利要求1所述的不饱和环取代二酸酯化合物,其特征在于,所述通式(Ⅰ)的化合物包括下述通式(Ⅱ)的化合物:
其中R1-R6基团如通式(Ⅰ)中的定义。
3.根据权利要求2所述的不饱和环取代二酸酯化合物,其特征在于,所述通式(Ⅱ)的化合物包括下述通式(Ⅲ)的化合物:
其中R1、R2基团如通式(Ⅰ)中的定义,R’为相同或不相同的氢、卤原子、直链或支链的C1-C20烷基,C3-C20环烷基,C6-C20芳基,C7-C20烷芳基和C7-C20芳烷基。
4.根据权利要求1所述的不饱和环取代二酸酯化合物,其特征在于,通式(Ⅰ)所述的化合物选自下列化合物:
3,5-二苯基2H吡咯-2,2-二甲酸二乙酯;3-(3-氯苯基)-5-甲基-吡咯-2,2-二甲酸二乙酯;3-(3-溴苯基)-5-甲基-吡咯-2,2-二甲酸二乙酯;二乙基-3-(对氯苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;芴-9,9-二甲酸二甲酯;芴-9,9-二甲酸二乙酯;芴-9,9-二甲酸二正丙酯;芴-9,9-二甲酸二异丙酯;芴-9,9-二甲酸二正丁酯;芴-9,9-二甲酸二异丁酯;芴-9,9-二甲酸二正戊酯;芴-9,9-二甲酸二正己酯;芴 -9,9-二甲酸二正庚酯;芴-9,9-二甲酸二正辛酯;9-甲酸甲酯-9-甲酸乙酯-芴;9-甲酸甲酯-9-甲酸正丙酯-芴;9-甲酸甲酯-9-甲酸异丙酯-芴;9-甲酸甲酯-9-甲酸正丁酯-芴;9-甲酸甲酯-9-甲酸异丁酯-芴,9-甲酸乙酯-9-甲酸正丙酯-芴;9-甲酸乙酯-9-甲酸异丙酯-芴;9-甲酸乙酯-9-甲酸正丁酯-芴;9-甲酸乙酯-9-甲酸异丁酯-芴;二甲基4H-苯并<g>硫杂<2,3-e>吲唑-4,4-二甲酸酯;二乙基-5-苯基-3(对甲苯)2H-吡咯-2,2-甲酸酯;二乙基-3(对甲氧基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二乙基5-(对硝基)-3-苯基-2H-吡咯-2,2-二甲酸酯;二乙基-2,3-二苯基-1H-茚-1,1-二甲酸酯;二乙基-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-2-(4-氯苯)-1H-茚-1,1-二甲酸酯;二乙基-2-(4-甲氧基苯基)-1H-茚-1,1-二甲酸酯;二甲基3-(4-甲基苯)-2-苯基-1H-茚-1,1-二甲酸酯;二甲基-3-(4-硝基苯)-1H-茚-1,1-二甲酸酯;二甲基氨基-4-五甲氧羰基-1,2,3,5,5-五甲氧羰基环戊二烯;3-苯基-茚-1,1-二甲酸甲酯;二甲基-5-(对氯苯)3-苯基-2H-吡咯-2,2-二甲酸酯;二甲基3,4-二(对氯苯)2H-吡咯-二甲酸酯;二甲基3-(对-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基3-(间-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基5-(间-硝基苯)-5-苯基-2H-吡咯-2,2-二甲酸酯;二甲基5,6-二甲基-5H,6H-环戊二吲哚-11,11-二甲酸酯;1-(2-硝基苯硫)-2,3,4,5,5-甲酸甲酯-环戊二烯;1-(2,4-二硝基苯)-2,3,4,5,5-五甲酸甲酯-环戊二烯;甲基-2-叔丁基-3-甲基-1H-茚-1,1-二甲酸酯;二甲基3-甲基-2-三甲基硅-茚-1,1-二甲酸酯;二甲基3-甲基-2-苯基-茚-1,1-二甲酸酯;二乙基-2,3-二-正丙基-1H-茚-1,1-二甲酸酯;二甲基-3-羟甲基-2-苯基-1H-茚-1,1-二甲酸酯;二甲基-2-叔丁基-5,6-二甲氧基-3-甲基-1H-茚-1,1-二甲酸酯;二甲基-2-苯基-3-(硫杂-2-yl)-1H-茚-1,1-二甲酸酯;二甲基-3-(2-甲苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基3-(2-甲氧羰基苯基)-2苯基-1H-茚-1,1-二甲酸酯;二甲基3-(4-三氟甲基苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基3-(4-乙酰苯)2-苯基-1H-茚-1,1-二甲酸酯;二甲基-2-(环己1-烯)-3-(4-乙酰苯)-1H-茚-1,1-二甲酸酯;二甲基2-[(乙氧酰基)甲基]-1H-茚-1,1-二甲酸酯;1,1-二乙基-1H-茚-1,1-二甲酸酯;7-氯-5甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;5-氯-7-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;5-氨基-7-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;7-甲氧基-5-甲基-吡唑[4,3-d]嘧啶-3,3-二甲酸乙酯;1-对甲苯氨基-2,3,4,5,5-五甲氧羰基环戊二烯;二甲基-3H-菲并〈9,10-c〉吡唑-3,3-二甲酸酯;3,3-二(甲氧羰基)-3H-吲唑;3,3-二(乙氧羰基)3H-吲唑;1-三氯甲基-2,3,4,5,5-五甲氧羰基环戊二烯;1-(2-甲基-4-硝基苯)-五甲氧羰基环戊二烯;1-(2-碘-4-硝基苯)-五甲氧羰基环戊二烯;2-(2-碘-4-硝基苯)-1,3,4,5,5-五甲氧羰基环戊二烯;1-(2,4-二硝基苯)-2,3,4,5,5-五甲氧羰基环戊二烯;4-苄基-1,2,3,5,5-五聚(甲氧羰基)环戊二烯;3-苄基-1,2,4,5,5-五聚(甲氧羰基)环戊二烯;2-(三氟甲基)-5-羰基-3,3-二(甲氧羰基)-3H-吲哚;2-(三 氟甲基)-5-羰基-7-甲基-3,3-二(甲氧羰基)-3H-吲哚;3-(三氟甲基)-5-羟基-7-甲氧基-3,3-二(甲氧羰基)-3H-吲哚;二乙基-3-苯基-5(对甲苯)2H-吡咯-2,2-二甲酸酯;二乙基-2-(4-氯苯)-5-吗啉-4H-咪唑-4,4-二甲酸酯;4,5,5-三甲酸甲酯-1,2,3-三氯环戊二烯;甲基-3-甲基-4-三甲基硅-环戊-2,4-二烯-1,1-二甲酸酯;二乙基-2,5-二苯基-4H-咪唑-4,4-二甲酸酯;二乙基-3-苄基-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(4-(甲氧羰基)苯基)2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(4-乙酰基苯)2-苯基-1H-茚-1,1-二甲酸酯;二乙基-2-甲氧甲基-1H-茚-1,1-二甲酸酯;二甲基-2-叔丁基-1H-茚-1,1-二甲酸酯;二乙基-2-叔丁基-1H-茚-1,1-二甲酸酯;二甲基2-正丁基-1H-茚-1,1-二甲酸酯;二乙基2-正丁基-1H-茚-1,1-二甲酸酯;二乙基2-正己基-1H-茚-1,1-二甲酸酯;二乙基-2-(3-氰基-1-丙基)-1H-茚-1,1-二甲酸酯;二乙基-2-二乙氧甲基-1H-茚-1,1-二甲酸酯;二乙基-2-(4-甲氧苯基)-1H-茚-1,1-二甲酸酯;二乙基-2-(1-环己烯)-1H-茚-1,1-二甲酸酯;二乙基-2-(环己基)-1H-茚-1,1-二甲酸酯;二乙基-3-(3-甲苯)-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-(3-硝基苯)-2-苯基-1H-茚-1,1-二甲酸酯;二乙基13H-茚并[1,2-e]-菲-13,13-二甲酸酯;二乙基-2-己基-3-(4-甲氧苯基)1H-茚-1,1-二甲酸酯;环戊[c]硫杂-5,5-二甲酸乙酯;4-[4-[4-(甲基磺酸)苯]1,1-二(甲氧基)环戊-2,4-二烯-3-基]吡啶;芴-4,9,9-二甲酸-4-叔丁基-9,9-二甲酯;4-(4-氨基-吡啶-3-基氨甲酰基)-芴-9,9-二甲酸甲酯;4-(3-氨基-吡啶-4-基氨甲酰基)-芴-9,9-二甲酸二甲酯;二乙基-3-碘-2-苯基-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-正戊基-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-(3甲氧苯基)-1H-茚-1,1-二甲酸酯;二乙基-3-碘-2-(萘-2-基)-1H-茚-1,1-二甲酸酯;二正己基-芴-9,9-二甲酸酯;二正庚基-芴-9,9-二甲酸酯;二乙基-2-苯-3H-茚-3,3-二甲酸酯;二乙基-2-溴-1H-茚-1,1-二甲酸酯;
1-乙基-1-甲基-环己-2,5-二烯-1,1-二甲酸酯;N,4,4-三乙氧碳基-1,4-二氢-吡啶;2,6-二苯基-4,4-二甲氧羰基-4H-吡喃;2,6-二苯基-4,4-二甲氧羰基-1,4-二氢吡啶;2,6-二(4-氯苯)-4,4-二甲氧羰基-4H-吡喃;2,6-二(4-甲氧苯基)-4,4-二甲氧羰基-4H-吡喃;2,6-二(4-氯苯)-4,4-二甲氧羰基-1,4-二氢吡啶;2,6-二(4-甲氧苯基)-4,4-二甲氧羰基-1,4-二氢吡啶;1-环戊基-4,4-二(甲氧羰基)-1,4-二氢吡啶;1-正己基-4,4-二(甲氧羰基)-1,4-二氢吡啶;1-甲氧-6,6-二甲酰氧甲基-环己-1,4-二烯;二甲基1,4-二氢萘-1,1-二甲酸酯;2,6-二(4-氯苯)-4,4-二甲氧酰基-4H-噻喃;二乙基-3-溴-1,4-二氢-1-甲基pyridazino[3,4-b]喹喔啉-4,4-二甲酸酯;二乙基-5-溴-3-苯基-1,4-二氢哒嗪-4,4-二甲酸酯;三己基-3-苯基-1,4-二氢哒嗪-4,4,5-三甲酸酯;1-苯乙基-二(甲氧酰基)1,4-二氢吡啶;二乙基-2-甲基-6-苯(4H-吡喃)4,4-二甲酸酯;1-(2-萘甲基)-4,4-二(甲氧酰基)-1,4-二氢吡啶;二甲基-3-乙酰基-1-甲基喹啉-4,4(1H)-二甲酸酯。
5.一种权利要求1-4任意一项所述的不饱和环取代二酸酯化合物的制备方法,其特征在于,包括如下步骤:将相应的不饱和环取代化合物制备得环取代甲酸,再与相应的醇R1OH反应酯化为甲酸酯,或者与合适的酯类前体直接加成为不饱和环取代甲酸酯;将上步产物与与合适的含酸酯基的前体加成即得产物。
6.一种权利要求1-4任意一项所述的不饱和环取代二酸酯化合物的制备方法,其特征在于,当所述的不饱和环取代二酸酯化合物R1和R2相同时,采用相应的不饱和环化合物直接与锂试剂和卤代甲酸酯一步反应制备得到。
7.权利要求1-4任意一项所述的不饱和环取代二酸酯化合物在制备烯烃聚合催化剂中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410265537.0A CN104058967A (zh) | 2014-06-13 | 2014-06-13 | 适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410265537.0A CN104058967A (zh) | 2014-06-13 | 2014-06-13 | 适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104058967A true CN104058967A (zh) | 2014-09-24 |
Family
ID=51546941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410265537.0A Pending CN104058967A (zh) | 2014-06-13 | 2014-06-13 | 适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104058967A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105541623A (zh) * | 2014-11-03 | 2016-05-04 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物和其应用 |
KR101619409B1 (ko) * | 2014-11-28 | 2016-05-10 | 롯데케미칼 주식회사 | 폴리올레핀 중합용 촉매 조성물, 고체 촉매의 제조방법, 및 이를 이용한 폴리올레핀의 제조방법 |
KR101621001B1 (ko) * | 2014-11-28 | 2016-05-13 | 롯데케미칼 주식회사 | 폴리올레핀 중합용 촉매 조성물, 고체 촉매의 제조방법, 및 이를 이용한 폴리올레핀의 제조방법 |
CN105622410A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物及其应用 |
CN105622804A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种用于烯烃聚合的固体催化剂组分、催化剂及应用 |
CN105622416A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物的制备方法 |
CN105622797A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种用于烯烃聚合的固体催化剂组分、催化剂和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1735632A (zh) * | 2003-01-22 | 2006-02-15 | 出光兴产株式会社 | 烯烃聚合用催化剂和制备烯烃聚合物的方法 |
CN1743346A (zh) * | 2004-09-02 | 2006-03-08 | 中国石油化工股份有限公司 | 用于烯烃聚合反应的催化剂组分和催化剂 |
KR20120002790A (ko) * | 2010-07-01 | 2012-01-09 | 삼성토탈 주식회사 | 프로필렌 중합용 고체촉매의 제조방법 |
-
2014
- 2014-06-13 CN CN201410265537.0A patent/CN104058967A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1735632A (zh) * | 2003-01-22 | 2006-02-15 | 出光兴产株式会社 | 烯烃聚合用催化剂和制备烯烃聚合物的方法 |
CN1743346A (zh) * | 2004-09-02 | 2006-03-08 | 中国石油化工股份有限公司 | 用于烯烃聚合反应的催化剂组分和催化剂 |
KR20120002790A (ko) * | 2010-07-01 | 2012-01-09 | 삼성토탈 주식회사 | 프로필렌 중합용 고체촉매의 제조방법 |
Non-Patent Citations (9)
Title |
---|
LI-NA GUO ET AL.: "Synthesis of Fused Polycycles from Propargylic Compounds with Terminal Alkynes via a Palladium-Catalyzed Tandem C-H Activation/Biscyclization Process", 《ORGANIC LETTERS》, vol. 9, no. 26, 22 November 2007 (2007-11-22), pages 5425 - 5428 * |
MICHAEL BUTTERS ET AL.: "An unexpected Prins desymmetrisation reaction", 《ARKIVOC》, 31 December 2012 (2012-12-31), pages 114 - 126 * |
NO: "no", 《ZCAPLUS数据库》, 22 December 2005 (2005-12-22), pages 1 - 2 * |
P. M. G. BAVIN: "Characterization of alkyl halides", 《ANAL. CHEM.》, vol. 32, no. 4, 30 April 1960 (1960-04-30), pages 554 - 556 * |
SHUNTARO MATAKA ET AL.: "Thermolysis of Dimethyl 3,3- (2,2-Biphenylyl)-3 H-pyrazole-4,5-dicarboxylate", 《J. ORG. CHEM.》, vol. 46, no. 9, 31 December 1981 (1981-12-31), pages 1929 - 1931 * |
TIENAN JIN ET AL.: "Gold-Catalyzed Intramolecular Carbocyclization of Alkynyl Ketones Leading to Highly Substituted Cyclic Enones", 《ORG. LETT.》, vol. 9, no. 25, 8 November 2007 (2007-11-08), pages 5259 - 5262 * |
V. M. BOITSOV ET AL.: "Dehydrohalogenation of Substituted Diethyl Halocyclopropane-1,1-dicarboxylates", 《RUSSIAN JOURNAL OF ORGANIC CHEMISTRY》, vol. 40, no. 12, 31 December 2004 (2004-12-31), pages 1760 - 1763, XP019301729 * |
YANYING ZHANG ET AL.: "Synthesis and oxidative polymerization of dialkyl fluorene-9,9-dicarboxylates", 《TETRAHEDRON LETTERS》, vol. 50, no. 44, 21 August 2009 (2009-08-21), pages 6057 - 6059, XP026602574, DOI: doi:10.1016/j.tetlet.2009.08.052 * |
许招会等: "聚丙烯催化剂内给电子体9,9-双(乙酸甲酯基)芴的合成与表征", 《石油炼制与化工》, vol. 40, no. 11, 30 November 2009 (2009-11-30), pages 28 - 31 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105541623A (zh) * | 2014-11-03 | 2016-05-04 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物和其应用 |
CN105622410A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物及其应用 |
CN105622804A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种用于烯烃聚合的固体催化剂组分、催化剂及应用 |
CN105622416A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种芴基团和羧酸酯结合的化合物的制备方法 |
CN105622797A (zh) * | 2014-11-03 | 2016-06-01 | 中国石油化工股份有限公司 | 一种用于烯烃聚合的固体催化剂组分、催化剂和应用 |
KR101619409B1 (ko) * | 2014-11-28 | 2016-05-10 | 롯데케미칼 주식회사 | 폴리올레핀 중합용 촉매 조성물, 고체 촉매의 제조방법, 및 이를 이용한 폴리올레핀의 제조방법 |
KR101621001B1 (ko) * | 2014-11-28 | 2016-05-13 | 롯데케미칼 주식회사 | 폴리올레핀 중합용 촉매 조성물, 고체 촉매의 제조방법, 및 이를 이용한 폴리올레핀의 제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104058967A (zh) | 适用于制备烯烃聚合催化剂的不饱和环取代二酸酯化合物 | |
CN1085661C (zh) | 作为神经激肽拮抗剂的哌啶衍生物 | |
CN103923237B (zh) | 用于烯烃聚合的催化剂组分及其应用 | |
CN105330836B (zh) | 一种端环氧基烯丙醇聚氧乙烯醚的合成方法 | |
CN101511761A (zh) | 在生产异蒲勒醇的过程中回收双(二芳基苯酚)配体 | |
CN104045748A (zh) | 用于烯烃聚合的固体催化剂组分及催化剂 | |
CN100494149C (zh) | 一种α,β-不饱和酮或芳酮的绿色合成方法 | |
CN104109213A (zh) | 用于烯烃聚合的催化剂组分及其催化剂 | |
EA029517B1 (ru) | Композиция катализатора полимеризации олефинов | |
CN103059175B (zh) | 烯烃聚合固体催化剂组分及其制备方法 | |
CN108727524B (zh) | 一种内给电子体化合物及催化丙烯聚合的催化剂 | |
CN105820111B (zh) | 一种催化剂的制备方法及其催化制备2,2-联吡啶的方法 | |
CN101948374B (zh) | 一种合成α-溴代酮并联产溴代烃的方法 | |
CN103380135B (zh) | 用于内酯类开环聚合的基于n-杂环卡宾的锆络合物 | |
CN109867596A (zh) | 一种反应精馏连续生产3-甲基-3-戊烯-2-酮的方法 | |
CN104250317A (zh) | 一种用于烯烃聚合反应的催化剂 | |
CN104017113A (zh) | 用于烯烃聚合的催化剂组分和含该催化剂组分的催化剂及其应用 | |
CN101195666B (zh) | 一种烯烃聚合用负载型催化剂及其制备方法 | |
CN102796029A (zh) | 化妆品级2-羟基-4-甲氧基二苯甲酮-5-磺酸清洁合成工艺 | |
CN101759564B (zh) | 一种酯类化合物及其在烯烃聚合催化剂中的应用 | |
CN100338015C (zh) | 用于制备烯烃聚合催化剂的二醇酯化合物 | |
CN106831887A (zh) | 一种桥联不对称双核茂金属化合物及其制备和应用 | |
JP5037901B2 (ja) | 不飽和カルボン酸フェニルの製造方法 | |
CN105622410A (zh) | 一种芴基团和羧酸酯结合的化合物及其应用 | |
KR101789386B1 (ko) | 고수율 및 고 광학순도의 광학활성 벤조티오펜계 화합물의 합성 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140924 |